Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-07-26

FDA Approved: TRETINOIN — Original Application (Obagi Cosmeceuticals LLC)

View source ↗

Summary

FDA approves Obagi Cosmeceuticals LLC's original application for a topical tretinoin product. This approval supports its use for acne vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRETINOIN (TRETINOIN)

Snippet

ORIG AP for TRETINOIN (TRETINOIN)